Elevated serum ACE levels in patients with post-acute COVID-19 syndrome.
- Resource Type
- Article
- Authors
- Mitchell, P D; Buckley, C; Subramaniam, A; Crowther, S; Donnelly, S C
- Source
- QJM: An International Journal of Medicine. Oct2022, Vol. 115 Issue 10, p651-652. 2p.
- Subject
- *POST-acute COVID-19 syndrome
*COVID-19
*SARS-CoV-2
*SARCOIDOSIS
*CORONAVIRUS diseases
- Language
- ISSN
- 1460-2725
We postulate that in those patients who developed long COVID syndrome along with an elevated serum ACE level may have developed an aberrant longer-term immune response to COVID infection. The serum ACE was elevated at 121 µ/l - normal 0-65 µ/l. The chest CT scan performed 5 months after the patients' acute COVID infection demonstrated extensive bilateral subpleural peripheral dense consolidation throughout both lungs. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current coronavirus disease (COVID-19) pandemic.[1] Over recent months, a plethora of novel research articles has been published, dealing with multiple aspects and manifestations of both the acute disease and its longer-term sequelae. [Extracted from the article]